M20-431 ABBV-CLS-484 Ph 1 2L Solid Tumors Study PTPN2i
ClinicalTrials.gov NCT04777994
Research payments
$150,864
Through program year 2024, $150,864 in research payments was reported against M20-431 ABBV-CLS-484 Ph 1 2L Solid Tumors Study PTPN2i, across 15 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT04777994
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $150,864 | 15 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Janice Mehnert New York, NY Named on 1 payment
- Eric Jonasch Houston, TX Named on 1 payment
- David Sommerhalder San Antonio, TX Named on 1 payment
- Lova Sun Philadelphia, PA Named on 1 payment
- Benedito Carneiro Filho Providence, RI Named on 1 payment
- Tanguy Lim Seiwert Baltimore, MD Named on 1 payment
- Jason Luke Pittsburgh, PA Named on 1 payment
- John Powderly Huntersville, NC Named on 1 payment
- Patricia Lo Russo Detroit, MI Named on 1 payment
- Jennifer Segar San Antonio, TX Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.